MIMMI, SELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.086
EU - Europa 765
AS - Asia 614
SA - Sud America 61
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 2.538
Nazione #
US - Stati Uniti d'America 1.028
SG - Singapore 420
IT - Italia 413
DE - Germania 118
CN - Cina 96
FI - Finlandia 60
BR - Brasile 55
SE - Svezia 55
CA - Canada 47
GB - Regno Unito 36
IN - India 27
FR - Francia 17
HK - Hong Kong 16
KR - Corea 14
JP - Giappone 9
MX - Messico 9
PL - Polonia 9
RO - Romania 9
CZ - Repubblica Ceca 8
ES - Italia 8
NL - Olanda 8
PT - Portogallo 5
BD - Bangladesh 4
RU - Federazione Russa 4
UA - Ucraina 4
VN - Vietnam 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
GR - Grecia 3
ID - Indonesia 3
TR - Turchia 3
AT - Austria 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IQ - Iraq 2
IR - Iran 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
IL - Israele 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PK - Pakistan 1
Totale 2.538
Città #
Singapore 218
Chandler 167
Munich 92
Catanzaro 79
Santa Clara 78
Milan 66
Lawrence 60
Princeton 60
Turku 47
Ashburn 33
Ottawa 31
Wilmington 30
Seattle 29
Boardman 27
London 26
Des Moines 20
Chicago 19
Rome 16
Hong Kong 14
Napoli 14
Los Angeles 13
Helsinki 12
Shanghai 11
São Paulo 10
Beijing 9
Brooklyn 9
Naples 9
Redmond 9
Taranto 9
Augusta 8
Olomouc 8
Redwood City 8
Foggia 7
Paris 7
Seoul 7
Guangzhou 6
Marano 6
Modena 6
New York 6
Norwalk 6
Chennai 5
Hanover 5
Pune 5
Teresina 5
The Dalles 5
Edmonton 4
Heidesheim 4
Latina 4
Montreal 4
Padova 4
Providence 4
Reggio Calabria 4
San Francisco 4
San Jose 4
Shenzhen 4
Tokyo 4
Târgu Mureş 4
Warsaw 4
Xi'an 4
Columbus 3
Crosia 3
Derby 3
Felgueiras 3
Ferrara 3
Florence 3
Huddinge 3
Lamezia Terme 3
Mumbai 3
Rio de Janeiro 3
Villanova d'Asti 3
Washington 3
Wuhan 3
Adrano 2
Amsterdam 2
Atlanta 2
Auckland 2
Aversa 2
Bagnara Calabra 2
Belgrade 2
Birmingham 2
Bonn 2
Caserta 2
Clarksburg 2
Clearwater 2
Clifton 2
Cosenza 2
Council Bluffs 2
Dalian 2
Dallas 2
Dalmine 2
Dubai 2
Genoa 2
Hangzhou 2
Hanoi 2
Ho Chi Minh City 2
Istanbul 2
Jiaxing 2
Johannesburg 2
Jülich 2
King of Prussia 2
Totale 1.468
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 108
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 79
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 76
PEPTIDI E LORO USI 68
A Candidate multi-targeting approach to block the CD98hc oncoprotein 67
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 66
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 52
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 52
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 51
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 51
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 51
A novel phage display based platform for exosome diversity characterization 49
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 47
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 46
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 46
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 45
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 45
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 45
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 45
Crucial role for IBtk in the survival and maintenance of mature B cells 44
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 43
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 43
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 41
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 40
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 39
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 38
PEPTIDE AND USES THEREO 38
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 37
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 37
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 37
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 36
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 35
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 35
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 35
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 35
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 34
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 34
Phage Display: An Overview in Context to Drug Discovery 34
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 34
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 33
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 33
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 33
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 32
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 32
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 31
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 31
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 30
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 29
Insights into Thymus Development and Viral Thymic Infections 29
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 29
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 28
Belantamab mafodotin in multiple myeloma 28
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 28
Phage Display: An Overview in Context to Drug Discovery 27
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 25
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 23
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 23
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 22
Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk 21
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 19
Peptide-guided targeting of GPR55 for anti-cancer therapy 18
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 18
Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy 16
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 15
Isatuximab in multiple myeloma 15
Peptide-guided targeting of GPR55 for anti-cancer therapy. 15
Neuronally Derived Extracellular Vesicles’ Oligomeric and p129-α-Synuclein Levels for Differentiation of Parkinson’s Disease from Essential Tremor 15
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 14
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 13
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 13
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 12
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 12
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 12
null 10
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 10
null 6
null 2
Totale 2.640
Categoria #
all - tutte 30.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 11 7 6 5 5 26 16 2 33 37 18 10
2021/2022268 6 2 13 56 20 12 15 60 19 34 29 2
2022/2023559 122 26 38 23 52 37 7 53 108 38 41 14
2023/2024312 59 38 31 23 21 65 6 10 6 6 17 30
2024/20251.042 130 39 46 38 98 104 27 26 145 25 146 218
2025/2026136 136 0 0 0 0 0 0 0 0 0 0 0
Totale 2.640